124 related articles for article (PubMed ID: 6266641)
1. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong.
Lai CL; Lam KC; Wong KP; Wu PC; Todd D
Cancer; 1981 Jun; 47(11):2746-55. PubMed ID: 6266641
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Noda Y; Fujita H; Bae KT
Eur J Radiol; 2015 May; 84(5):811-5. PubMed ID: 25650331
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
4. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.
Itoshima T; Kawaguchi K; Ukida M; Ito T; Hattori S; Kitadai M; Ogawa H; Mizutani S; Kita K; Tanaka R
Acta Med Okayama; 1984 Apr; 38(2):159-68. PubMed ID: 6203337
[TBL] [Abstract][Full Text] [Related]
7. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
Patel J; Yopp A; Waljee AK; Singal AG
J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
[TBL] [Abstract][Full Text] [Related]
8. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
Hanazaki K; Wakabayashi M; Sodeyama H; Kajikawa S; Amano J
Hepatogastroenterology; 1999; 46(30):3201-7. PubMed ID: 10626186
[TBL] [Abstract][Full Text] [Related]
9. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
[TBL] [Abstract][Full Text] [Related]
13. Aspartate aminotransferase-to-platelet ratio index is associated with liver cirrhosis in patients undergoing surgery for hepatocellular carcinoma.
Ishizuka M; Kubota K; Kita J; Shimoda M; Kato M; Mori S; Iso Y; Yamagishi H; Kojima M
J Surg Res; 2015 Mar; 194(1):63-8. PubMed ID: 25291961
[TBL] [Abstract][Full Text] [Related]
14. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
16. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.
Takagi H; Kakizaki S; Sohara N; Sato K; Tsukioka G; Tago Y; Konaka K; Kabeya K; Kaneko M; Takayama H; Hashimoto Y; Yamada T; Takahashi H; Shimojo H; Nagamine T; Mori M
Int J Vitam Nutr Res; 2003 Nov; 73(6):411-5. PubMed ID: 14743544
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
Abdelgawad IA
J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
[TBL] [Abstract][Full Text] [Related]
19. Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy.
Kim GM; Won JY; Kim MD; Park SI; Lee do Y; Shin W; Shin M; Han KH; Kim do Y; Kim SU
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1447-54. PubMed ID: 27256103
[TBL] [Abstract][Full Text] [Related]
20. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]